Effectiveness of Three Doses of mRNA COVID-19 Vaccines in the Hemodialysis Population during the Omicron Period

1Division of Nephrology, Department of Medicine, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada

2Ontario Renal Network, Ontario Health, Toronto, Ontario, Canada

3Health System Performance and Support, Ontario Health, Toronto, Ontario, Canada

4Department of Epidemiology & Biostatistics, Western University, London, Ontario, Canada

5ICES, Toronto, Ontario, Canada

6Lawson Health Research Institute, London, Ontario, Canada

7Dalla Lana School of Public Health, Centre for Vaccine Preventable Diseases, and Department of Family and Community Medicine, University of Toronto, Toronto, Ontario, Canada

8Public Health Ontario, Toronto, Ontario, Canada

9University Health Network, Toronto, Ontario, Canada

10Division of Nephrology, St. Michael's Hospital and the Keenan Research Center, Li Ka Shing Knowledge Institute, St. Michael's Hospital, University of Toronto, Toronto, Ontario, Canada

11British Columbia Provincial Renal Agency, Vancouver, British Columbia, Canada

12Division of Infectious Diseases, Department of Medicine, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada

13Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada

14St. Paul's Hospital, Vancouver, British Columbia, Canada

15Department of Medicine, Epidemiology and Biostatistics, Western University, London, Ontario, Canada

Correspondence: Dr. Matthew J. Oliver, Kidney Care Centre at the CNIB, 1929 Bayview Avenue, Room 388, Toronto, Ontario M4G 3E8, Canada. Email: [email protected]

Published online ahead of print. Publication date available at www.cjasn.org.

留言 (0)

沒有登入
gif